One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.

@article{Gregori2006OneyearSA,
  title={One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.},
  author={Ninel Z. Gregori and Philip J. Rosenfeld and Carmen A. Puliafito and Harry W. Flynn and Ji Eun Lee and Elias C Mavrofrides and William E. Smiddy and Timothy Garrett Murray and Audina M. Berrocal and Ingrid U. Scott and Giovanni Gregori},
  journal={Retina},
  year={2006},
  volume={26 8},
  pages={889-95}
}
PURPOSE To evaluate the safety and efficacy of intravitreal triamcinolone acetonide (IVTA) as treatment for macular edema associated with central retinal vein occlusion (CRVO). METHODS A retrospective review was performed of data for 40 consecutive patients (40 eyes) with CRVO and macular edema treated with IVTA at the Bascom Palmer Eye Institute (Miami, FL). RESULTS Median duration of symptoms before the first injection was 3 months (range, 1 day to 8 years). Median Snellen visual acuity… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 33 extracted citations

[Retinal vein occlusion: anti-VEGF treatments].

Journal francais d'ophtalmologie • 2009
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…